�ٺ���Ƶ

News from �ٺ���Ƶ Health

�ٺ���Ƶ Receives $75 Million Gift for New West Palm Beach Medical Tower. (Palm Beach Post (USA))

The (2/21) reports the Julia Koch Family Foundation has given �ٺ���Ƶ Health a $75 million donation to “build a medical office tower in West Palm Beach. �ٺ���Ƶ officials said the blockbuster gift will allow the non-profit health care provider to dramatically expand medical services for existing and new patients in Florida.”

The (2/21) reports the facility will “offer 76,000 square feet of clinical space, including on-demand specialty care in a wide range of areas including internal medicine, primary care, oncology and pain management.” Robert I. Grossman, MD, dean and CEO, �ٺ���Ƶ Health, said, “Since our arrival in 2017, demand continues to grow in Florida for the exceptional care our teams are already known for in New York.” He added, “Thanks to the incredible generosity of the Julia Koch Family Foundation, we will be able to offer even more patients one high standard of care in a beautiful new location where our teams can seamlessly coordinate between Florida and New York.”

Perlmutter Cancer Center at �ٺ���Ƶ Health Names New Neuro-oncology Chief. (Healio)

(2/20) reports, “Alexandra Miller, MD, PhD, chief, Division of Neuro-Oncology, Brain and Spine Tumor Center, Perlmutter Cancer Center.” Miller “is a neurologist and neuro-oncologist specializing in the treatment of primary brain tumors. She previously served as the chief of neurology resident and chief neuro-oncology fellow at Memorial Sloan Kettering Cancer Center.”

Segregated Residential and Transplant Center Neighborhoods Contribute to Disparities. (Healio)

(2/19) Discussing their research on disparities in access to kidney transplants between Black and white patients, Yiting Li, MPH, senior data analyst, Center for Surgical & Transplant Applied Research, said, “Live donor kidney transplantation (LDKT) remains the preferred method of kidney replacement therapy.”

Episode 11: From Toxic Positivity to Practical Optimism with Dr. Sue Varma. (Nutritious Life)

(2/20) Sudeepta Varma, MD, clinical assistant professor, Department of Psychiatry at �ٺ���Ƶ, discussed the balance between optimism and “toxic positivity.”

AAOS: Sports-Related Orthopedic Injuries in Seniors Projected to Grow 123 Percent by 2040. (Drug Information Online)

(2/20) A new study suggests “sports-related injuries among older adults are expected to increase 123 percent between 2021 and 2040,” with Jay Zaifman, MD, resident, Department of Orthopedic Surgery in New York City, saying, “There are traditionally different protocols and treatments for this age group. We now need to consider the new higher demands of many of these patients. Taking a patient-centered approach and rethinking our standard of care for more active older adults is crucial.”
Also reporting is (2/20).

“Magic Mushrooms” Are Making a Comeback, Particularly in the Midwest. Here’s Why. (Cincinnati Enquirer)

The (2/20) Research funded by the National Institute on Drug Abuse “shows a dramatic rise in law enforcement seizures across the United States – and particularly in the Midwest – of psilocybin mushrooms,” with Joseph J. Palamar, MPH, PhD, associate professor, Department of Population Health at New York University Langone Health, saying, “I believe more people are using shrooms, but we’re lacking data that shows increasing trends in use, largely because most drug surveys used don’t specifically ask about shroom use.”

Women Gain More Years of Life from Exercising Less than Men. (Everyday Health)

(2/15) New research shows that health and longevity gains from exercise “may vary significantly between the sexes – with women getting more benefit with less time spent,” with Nieca Goldberg, MD, clinical associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology at �ٺ���Ƶ Medical Center, saying, “Men and women have physiologic differences when it comes to exercise, but most of our exercise guidelines and protocols are based on the exercise response of men.”

COVID Vaccines Linked to Slight Increases in Heart, Brain, Blood Disorders: Study. (New York Post)

The (2/20) New research suggests COVID-19 vaccines “have been linked to rare occurrences of heart, brain and blood disorders,” with Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine at �ٺ���Ƶ Medical Center, saying, “The massive study and review of the data reveals some rare association of the mRNA vaccines and myocarditis, especially after the second shot, as well as an association between the Oxford Astra Zeneca adenovirus vector vaccines and Guillain-Barre syndrome.”
Also reporting are (2/20) and the (2/20).

Tax Records Reveal the Lucrative World of Covid Misinformation. (Washington Post)

The (2/21) Discussing groups that have profited from spreading misinformation about the COVID-19 pandemic, Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, said, “These groups gave jet fuel to misinformation at a crucial time in the pandemic. The richer they get, the worse off the public is because, indisputably, they’re spouting dangerous nonsense that kills people.”

Musk Claims Neuralink Patient Doing OK with Implant, Can Move Mouse with Brain. (Ars Technica)

(2/20) Discussing Neuralink cofounder Elon Musk’s announcements about progress in the firm’s efforts to implant chips in human brains, Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, and Jonathan Moreno, a University of Pennsylvania medical ethics professor, wrote, “Science by press release, while increasingly common, is not science.”

News from �ٺ���Ƶ Hospital—Long Island

Getting to Know Dr Doug Marks, Oncology Clinical Trialist. (American Journal of Managed Care)

The (2/20) Douglas K. Marks, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, �ٺ���Ƶ Hospital–Long Island”; he said, “I’ve really enjoyed working with oncologists treating all types of different cancers, to similarly empower them to have the trials that they need for their patients.”